Helping smokers quit using tailored digital messages
Official title: Behavioral Intervention to Mitigate Nicotine Addiction in Digital Environments
Funded at Georgia State University · NIH-11065544 · Data updated 2026-11-12
This study is looking at a new way to help smokers, especially those who use flavored tobacco, quit by creating and testing helpful digital messages that encourage them to stop smoking.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgia State University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | April 3, 2024 |
| Project end | March 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $579,317 |
| NIH project number | 5R01CA289552-02 |
| Project ID | NIH-11065544 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adult smokers, especially those from socioeconomically disadvantaged backgrounds who use flavored tobacco products.
✕Less likely to help
Patients who do not smoke or those who are not interested in quitting smoking may not benefit from this research.
What this research studies
This research investigates a behavioral intervention aimed at reducing nicotine addiction among smokers, particularly those using flavored tobacco products. It employs a multi-phase approach that includes qualitative methods and workshops to create effective digital messages for smoking cessation. These messages will be tested through eye-tracking studies and a randomized clinical trial to assess their impact on quitting behaviors. The goal is to enhance tobacco education and improve cessation outcomes for smokers.
Why it matters
Potential benefit: If successful, this research could provide smokers with more effective tools and strategies to quit smoking, particularly in disadvantaged populations.
How similar studies have gone: Previous research has shown promise in using tailored messaging for smoking cessation, indicating that this approach could be effective.
Where this research is happening
-
Georgia State University
Atlanta, United States Active
Researchers
- Principal investigator: Popova, Lyudmila — Georgia State University
- Study coordinator: Popova, Lyudmila
Related research
Other NIH-funded projects on the same topics.
-
Reducing Addiction Risk in High Schools Through Better Prevention Infrastructure
Aims to build a sustainable, school-based system to prevent opioid and other drug use among high school students, especially those at higher risk.
-
HEAL Data Platform to share addiction-related data across programs
A platform project to make HEAL data from many programs easier to find and use, helping researchers and clinicians access information about addiction in children and youth.
-
Cognitively-enhanced tDCS to reduce cocaine craving
A study to test whether real brain stimulation together with learning strategies can lessen craving in people with cocaine use disorder.
-
Yale center researching how tobacco products affect use and addiction in people
A Yale research center is studying how nicotine, flavor additives, and other ingredients in tobacco products influence people’s likelihood of starting and becoming addicted.
-
Atherosclerosis in cocaine addiction: imaging risk with PET/MR
This project uses PET/MR imaging to look for early artery disease in people with cocaine use disorder to help prevent strokes or other brain injuries.
-
Integrating long-acting PrEP into street medicine for people who use drugs
This project tests whether a long-acting HIV prevention shot (lenacapavir) can be feasibly and acceptably offered by street-based health teams to people who use drugs.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.